4//SEC Filing
Discordia Robert Paul 4
Accession 0001209191-19-045053
CIK 0001595097other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 9:22 AM ET
Size
5.6 KB
Accession
0001209191-19-045053
Insider Transaction Report
Form 4
Discordia Robert Paul
Chief Operating Officer
Transactions
- Award
Stock Option(right to buy)
2019-08-06+100,000→ 100,000 totalExercise: $5.64Exp: 2029-08-06→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on August 6, 2020, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on September 6, 2020.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001784644
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 9:22 AM ET
- Size
- 5.6 KB